These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 6119682)

  • 21. Antihistaminic-opioid combination: effect on locomotor activity in mice.
    Sansone M
    Pol J Pharmacol Pharm; 1988; 40(5):515-23. PubMed ID: 3253717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Some central effects of tiflucarbine, a new potential antidepressant drug.
    Maj J; Rogóz Z; Sowińska H; Zalewski Z
    Pol J Pharmacol Pharm; 1987; 39(1):63-74. PubMed ID: 2823240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of antihistaminics on cataleptogenic action of analgesics and haloperidol.
    Malec D; Langwiński R
    Pol J Pharmacol Pharm; 1983; 35(4):293-300. PubMed ID: 6141553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of antihistamine drugs on the neuroleptic-induced catalepsy.
    Pawłowski L; Sidorowicz L
    Pol J Pharmacol Pharm; 1978; 30(5):665-73. PubMed ID: 35784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of morphine-induced hyperactivity by antihistaminic drugs in mice.
    Sansone M; Castellano C; D'Amato FR
    Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):239-45. PubMed ID: 2881522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological profile of venlafaxine, a new antidepressant, given acutely.
    Rogóz Z; Dziedzicka-Wasylewska M; Maj J
    Pol J Pharmacol; 1998; 50(2):107-15. PubMed ID: 9798262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 1-Pyridyl-3,4-dihydro-beta-carbolines: synthesis and central action.
    Misztal S; Boksa J; Chojnacka-Wójcik E; Tatarczyńska E; Wiczyńska B
    Pol J Pharmacol Pharm; 1986; 38(5-6):555-65. PubMed ID: 3494988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of antidepressants and antihistaminics on catalepsy induced by intracerebroventricular administration of histamine in mice.
    Onodera K
    Methods Find Exp Clin Pharmacol; 1991; 13(6):397-403. PubMed ID: 1679150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antidepressant profile of bupropion and three metabolites in mice.
    Martin P; Massol J; Colin JN; Lacomblez L; Puech AJ
    Pharmacopsychiatry; 1990 Jul; 23(4):187-94. PubMed ID: 2116631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of a number of drugs with different pharmacological properties upon reserpine induced hypothermia in mice.
    van Riezen H; Delver A
    Arzneimittelforschung; 1971 Oct; 21(10):1562-6. PubMed ID: 4400402
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of intracerebroventricular injection of histamine and its related compounds on rectal temperature in mice.
    Chen Z; Sugimoto Y; Kamei C
    Methods Find Exp Clin Pharmacol; 1995 Dec; 17(10):669-75. PubMed ID: 9053587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central effects of repeated treatment with bupropion.
    Klimek V; Nowak G; Czyrak A
    Pol J Pharmacol Pharm; 1985; 37(3):243-52. PubMed ID: 3934652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Differences in the mechanisms of the stimulant and antidepressive effects of nomifensine].
    Chermat R; Poncelet M; Simon P
    J Pharmacol; 1985; 16(1):7-13. PubMed ID: 2860270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central effects of SL 82.0715, an antagonist of polyamine site of the NMDA receptor complex.
    Dereń-Wesołek A; Maj J
    Pol J Pharmacol; 1993; 45(5-6):467-80. PubMed ID: 7912135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo characterization of T-794, a novel reversible inhibitor of monoamine oxidase-A, as an antidepressant with a wide safety margin.
    Kato M; Katayama T; Iwata H; Yamamura M; Matsuoka Y; Narita H
    J Pharmacol Exp Ther; 1998 Mar; 284(3):983-90. PubMed ID: 9495858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological profile of reboxetine, a representative of new class of antidepressant drugs, selective noradrenaline reuptake inhibitor (NARI), given acutely.
    Rogóz Z; Wróbel A; Krasicka-Domka M; Maj J
    Pol J Pharmacol; 1999; 51(5):399-404. PubMed ID: 10817540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The action of compound WA-335 on the central nervous system.
    Maj J; Baran L; Sowińska H; Gancarczyk L
    Arch Immunol Ther Exp (Warsz); 1976; 24(2):205-22. PubMed ID: 945051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The new versus the old antidepressant drugs: a comparative study of their psychopharmacological profiles (author's transl)].
    Bourin M; Puech AJ; Chermat R; Doare L; Poncelet M; Simon P
    Encephale; 1981; 7(3):235-42. PubMed ID: 7285851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antidepressive effects of 3 endogenous monoamines: psychopharmacologic profiles of noradrenaline, octopamine and phenethylamine].
    Bulach C; Doaré L; Massari B; Simon P
    J Pharmacol; 1984; 15(1):1-15. PubMed ID: 6425565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antidepressant activity of S-adenosyl-L-methionine in mice and rats.
    Czyrak A; Rogóz Z; Skuza G; Zajaczkowski W; Maj J
    J Basic Clin Physiol Pharmacol; 1992; 3(1):1-17. PubMed ID: 1504060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.